TDP-43 impairs sleep in Drosophila through Ataxin-2 –dependent metabolic disturbance
Science Advances · 2024
DOI: 10.1126/sciadv.adj4457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Alexandra E Perlegos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Graduate Group, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Neurodegenerative Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal dementia are associated with substantial sleep disruption, which may accelerate cognitive decline and brain degeneration. Here, we define a role for trans-activation response element (TAR) DNA binding protein 43 (TDP-43), a protein associated with human neurodegenerative disease, in regulating sleep using Drosophila . Expression of TDP-43 severely disrupts sleep, and the sleep deficit is rescued by Atx2 knockdown. Brain RNA sequencing revealed that Atx2 RNA interference regulates transcripts enriched for small-molecule metabolic signaling in TDP-43 brains. Focusing on these Atx2 -regulated genes, we identified suppressors of the TDP-43 sleep phenotype enriched for metabolism pathways. Knockdown of Atx2 or treatment with rapamycin attenuated the sleep phenotype and mitigated the disruption of small-molecule glycogen metabolism caused by TDP-43. Our findings provide a connection between toxicity of TDP-43 and sleep disturbances and highlight key aspects of metabolism that interplay with TDP-43 toxicity upon Atx2 rescue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neuroscience Graduate Group, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
- Department of Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
- National Institute of Neurological Disorders & Stroke, National Institutes of Health, Bethesda, MD, 20892, USA.
- Department of Neuroscience, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
- Chronobiology Sleep Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
ORCID-Profile: Alexandra E Perlegos, Jaclyn Durkin, Samuel J Belfer, Anyara Rodriguez, Oksana Shcherbakova, Kristen Park, Jenny Luong, Nancy M Bonini, Matthew S Kayser
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
- NIH HHS
- NIMH NIH HHS
- NIGMS NIH HHS
- NINDS NIH HHS
Zitieren
APA
Perlegos, A. E., Durkin, J., Belfer, S. J., Rodriguez, A., Shcherbakova, O., Park, K., Luong, J., Bonini, N. M., & Kayser, M. S. (2024). TDP-43 impairs sleep in Drosophila through Ataxin-2 –dependent metabolic disturbance. Science Advances. https://doi.org/10.1126/sciadv.adj4457
Vancouver
Perlegos AE, Durkin J, Belfer SJ, Rodriguez A, Shcherbakova O, Park K, et al. TDP-43 impairs sleep in Drosophila through Ataxin-2 –dependent metabolic disturbance. Science Advances. 2024. doi:10.1126/sciadv.adj4457
BibTeX
@article{Perlegos2024,
author = {Perlegos, Alexandra E and Durkin, Jaclyn and Belfer, Samuel J and Rodriguez, Anyara and Shcherbakova, Oksana and Park, Kristen and Luong, Jenny and Bonini, Nancy M and Kayser, Matthew S},
title = {TDP-43 impairs sleep in Drosophila through Ataxin-2 –dependent metabolic disturbance},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adj4457}
}
EUVIMED